Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Open

SectorGezondheidszorg

32.52 8.54

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.7

Max

30.87

Belangrijke statistieken
By Trading Economics
Inkomsten	-1.1M -19M
Verkoop	137K 401K
EPS	-0.241
Winstmarge	-4,633.666
Werknemers	116
EBITDA	-1.7M -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	-2.32% downside

Dividenden
By Acuity
Volgende Winsten	6 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	464M 2B
Vorige openingsprijs	23.98
Vorige sluitingsprijs	32.52

Nieuwssentiment

By Acuity

20%

80%

33 / 340 Rangschikking in Healthcare

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 jul 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21 jul 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 jul 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

-2.32% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 32 USD -2.32%

Hoogste 32 USD

Laagste 32 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

33 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.